MAP – Molecular Analysis for Precision Oncology is the leading congress in precision medicine in oncology in Europe, established by key opinion leaders in the field. Founded by Jean-Charles Soria, Fabrice André and Charles Swanton, the MAP Congress has established itself as a point of reference for all specialists wishing to create a bright future for precision medicine in oncology, by delivering a highly specific, minimally toxic and dramatically effective treatment for each patient.
Unicancer, CRUK and ESMO are glad to announce that, due to the Coronavirus pandemic, this year’s edition will be held virtually on October 9-10: MAP 2020 will offer the same top-tier scientific research and education and industry engagement that congress attendees are accustomed to, in an all-new digital environment.
We hope to see you online at our meeting in October!
More information
Abstract submission – Deadline: July 29th, 2020